Perkins Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$421K Buy
6,200
+900
+17% +$63.3K 0.01% 229
2016
Q4
$380K Buy
+5,300
New +$394K ﹤0.01% 233
2015
Q3
Sell
-2,600
Closed -$304K 248
2015
Q2
$304K Buy
2,600
+400
+18% +$43.7K ﹤0.01% 243
2015
Q1
$216K Buy
+2,200
New +$223K ﹤0.01% 256
2014
Q1
Sell
-20,941
Closed -$1.57M 264
2013
Q4
$1.57M Sell
20,941
-7,909
-27% -$551K 0.01% 239
2013
Q3
$1.81M Sell
28,850
-22,600
-44% -$1.35M 0.01% 236
2013
Q2
$2.63M Buy
+51,450
New +$2.68M 0.02% 234

Other funds holding GILD

Perkins Investment Management's GILD Position: Q1 2017 in Review

Perkins Investment Management increased its Gilead Sciences (GILD) stake by 17% in Q1 2017, buying an estimated $63.3K and bringing the position to 6,200 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #229.

Perkins Investment Management first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.63M in Q2 2013. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Perkins Investment Management held 6,200 shares of Gilead Sciences worth $421K as of Q1 2017.
  • Perkins Investment Management bought 900 Gilead Sciences shares in Q1 2017, an estimated $63.3K.
  • Gilead Sciences made up 0.01% of Perkins Investment Management's portfolio in Q1 2017, its #229 holding.
  • Perkins Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
  • Perkins Investment Management's Gilead Sciences position peaked at $2.63M in Q2 2013.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.